TrialAntimicrobial agents and chemotherapy2025

A phase I, single-center, randomized, open-label, three-period crossover study to evaluate the drug-drug interaction between ZSP1273 and oseltamivir in healthy Chinese subjects.

Yanqing Pang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.